Showing 1 - 10 of 2,570
Persistent link: https://www.econbiz.de/10011734578
may foster more and not less spending; in our simulation game, the financial investment in marketing key HCPs and HCOs …
Persistent link: https://www.econbiz.de/10012015756
Persistent link: https://www.econbiz.de/10011881395
Persistent link: https://www.econbiz.de/10014526234
Persistent link: https://www.econbiz.de/10010345405
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
Persistent link: https://www.econbiz.de/10012160308
Drug Policy of 1986
Persistent link: https://www.econbiz.de/10009323735
Persistent link: https://www.econbiz.de/10010504170
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014